Pen Needle Market Expected To Attain Around $4.8 Billion By 2025: Grand View Research Inc.

The global pen needles market is expected to reach a value of USD 4.8 billion by 2025, according to a new report by Grand View Research, Inc. Rising prevalence of diabetes is the primary reason for the significant growth of pen needles market. According to the International Diabetes Federation (IDF), nearly 415 million people were suffering from diabetes in 2015. Such a high prevalence of diabetes across the globe has led to rising demand for pen needles. Patients suffering from diabetes commonly use injectable pen devices, which helps in easy drug delivery.

In addition, obesity is a significant cause of diabetes. Obese people often suffer from type 2 diabetes, which makes them one of the highest revenue contributors of the target market. Thus, people with type 2 diabetes are the common target population for companies manufacturing pen needles.

Rising technological advancements is also expected to drive the market growth. Pen needles allow comfort and easy mode of insulin delivery. These devices are technologically advanced and provide a superior alternative drug delivery method in comparison to syringes and vials. For instance, in 2013, Becton, Dickinson and Company launched BD Ultra-Fine Nano 4mm Pen Needles with EasyFlow Technology, which will enable diabetic patients with easy adherence of insulin therapy regimens.

Access Full Research Report On Pen Needle Market Analysis: www.grandviewresearch.com/industry-analysis/pen-needles-market

Germany pen needles market, by product, 2014 – 2025 (USD Million)

Further Key Findings from the Study Suggest:

• Standard needles dominated the market in 2015 due to the availability of cost-effective needles as compared to safety needles

• Safety pen needles are anticipated to showcase lucrative growth over the forecast period due to the continuous technological advancements

• Amongst the needle lengths, 8mm held the largest share in 2015. This is due to the convenience offered by this needle type on diabetic patients

• Needle length of 4mm are expected to witness attractive CAGR over the forecast period owing to its short length

• Insulin therapy accounted for the largest market share in 2015 due to rising awareness regarding self-administration of insulin amongst the diabetic patients

• Europe dominated the market in 2015 followed by North America owing to high prevalence of diabetes in the European region

• Asia Pacific region is anticipated to exhibit the highest growth rate over the forecast period owing to the rising awareness levels amongst the diabetic population regarding easy drug delivery

• Some of the key players include Becton, Dickinson and Company, B. Braun Melsungen AG, Novo Nordisk A/S, Owen Mumford, Ltd., Ypsomed, HTL-STREFA, and TERUMO CORPORATION.

Browse More Reports Of This Category By Grand View Research At: www.grandviewresearch.com/industry/medical-devices

Germany pen needles market share, by therapy, 2015 (%)

Grand View Research has segmented the pen needles market on the basis of product, needle length, therapy and region:

Pen Needles Product Outlook (Revenue, USD Million; 2014 – 2025)

• Standard Pen Needles

• Safety Pen Needles

Pen Needles Length Outlook (Revenue, USD Million; 2014 – 2025)

• 4mm

• 5mm

• 6mm

• 8mm

• 10mm

• 12mm

Pen Needles Therapy Outlook (Revenue, USD Million; 2014 – 2025)

• Insulin

• Glucagon-like-Peptide-1 (GLP-1)

• Growth Hormone

Pen Needles Regional Outlook (Revenue, USD Million; 2014 – 2025)

• North America

  • U.S.

  • Canada

• Europe

  • Germany

  • UK

• Asia Pacific

  • China

  • India

• Latin America

  • Brazil

  • Mexico

• MEA

• South Africa

Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

For more information: www.grandviewresearch.com